DCK and cancer: After its entry into cancer cells, it is, first of all, phosphorylated by deoxycytidine kinase (dCK) and, subsequently, undergoes a series of phosphorylation steps that transform it into gemcitabine di- and tri-phosphate (dFdCDP and dFdCTP) [78].